Zepp Health Corporation (ZEPP) Revenue History
Annual and quarterly revenue from 2015 to present
ZEPP Revenue Over Time (2015–2025)
ZEPP Revenue Growth History
7 of 10 years with positive growth- FY2015 revenue growth
- N/A
- FY2016 revenue growth
- +75.9%
- FY2017 revenue growth
- +22.7%
- FY2018 revenue growth
- +89.6%
- FY2019 revenue growth
- +53.0%
- FY2020 revenue growth
- +4.9%
- FY2021 revenue growth
- +1.4%
- FY2022 revenue growth
- -31.7%
- FY2023 revenue growth
- -40.8%
- FY2024 revenue growth
- -46.6%
- FY2025 revenue growth
- +36.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $598.1M | +38.1% |
| Q3 2025 | $539.6M | +81.3% |
| Q2 2025 | $427.1M | +44.6% |
| Q1 2025 | $279.9M | -3.1% |
| Q4 2024 | $433.0M | -26.9% |
| Q3 2024 | $297.7M | -50.9% |
| Q2 2024 | $295.3M | -55.8% |
| Q1 2024 | $288.9M | -55.4% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2023)
ZEPP's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
By Geography
ZEPP Revenue Analysis (2015–2025)
Current Revenue & Growth
As of June 22, 2026, Zepp Health Corporation (ZEPP) generated trailing twelve-month (TTM) revenue of $1.84 billion, reflecting explosive growth of +38.1% year-over-year. The most recent quarter (Q4 2025) recorded $598.1 million in revenue, up 10.9% sequentially.
Historical Growth Trajectory
ZEPP's 5-year compound annual growth rate (CAGR) stands at -21.5%, indicating revenue contraction over this period. The 3-year CAGR of -24.5% is below the 5-year average, signalling a growth deceleration in recent years. Zepp Health Corporation's highest annual revenue of $6.17 billion was recorded in 2021.
Revenue by Segment
ZEPP's revenue is primarily driven by Manufactured Product, Other (74%), and Product (26%). With over half of revenue concentrated in Manufactured Product, Other, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Technology sector peers — including GRMN (+15.7% YoY), FOSL (-11.4% YoY), and SMPL (+6.3% YoY) — ZEPP has outperformed the peer group in revenue growth. Compare ZEPP vs GRMN →
ZEPP Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ZEPPCurrent | $1.8B | +38.1% | -21.5% | -11.3% | |
 GRMN | $7.2B | +15.7% | +11.6% | 25.9% | |
 FOSL | $1.0B | -11.4% | -9.0% | 2.3% | |
 SMPL | $1.5B | +6.3% | +12.2% | 15.1% | |
 AAPL | $416.2B | +12.8% | +8.7% | 32.0% | |
 FITB | $12.9B | - | - | 24.9% |
ZEPP Historical Revenue Data (2015–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.82B | +36.1% | $711.6M | 39.2% | $-204,934,260 | -11.3% |
| 2024 | $1.33B | -46.6% | $512.9M | 38.5% | $-345,041,274 | -25.9% |
| 2023 | $2.50B | -40.8% | $653.7M | 26.2% | $-215,522,459 | -8.6% |
| 2022 | $4.22B | -31.7% | $817.2M | 19.4% | $-417,447,389 | -9.9% |
| 2021 | $6.17B | +1.4% | $1.29B | 20.9% | $92.7M | 1.5% |
| 2020 | $6.08B | +4.9% | $1.26B | 20.7% | $164.7M | 2.7% |
| 2019 | $5.80B | +53.0% | $1.46B | 25.3% | $619.0M | 10.7% |
| 2018 | $3.79B | +89.6% | $976.1M | 25.8% | $380.0M | 10.0% |
| 2017 | $2.00B | +22.7% | $482.3M | 24.1% | $177.4M | 8.9% |
| 2016 | $1.63B | +75.9% | $288.9M | 17.7% | $14.0M | 0.9% |
| 2015 | $925.4M | - | $114.2M | 12.3% | $-41,408,376 | -4.5% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
11+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ZEPP — Frequently Asked Questions
Quick answers to the most common questions about buying ZEPP stock.
Is ZEPP's revenue growth accelerating or slowing?
ZEPP revenue growth is accelerating. TTM revenue reached $1.8B, up +38.1% year-over-year — ahead of the 5-year CAGR of -21.5%. This indicates the business is expanding faster than its historical baseline.
What is ZEPP's revenue history from 2015 to 2026?
Zepp Health Corporation (ZEPP) revenue history spans 2015 to 2026. TTM revenue as of 2026 is $1.8B, growing at +38.1% YoY. The 5-year CAGR is -21.5%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is ZEPP's long-term revenue growth rate (CAGR)?
Zepp Health Corporation's 5-year revenue CAGR of -21.5% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +38.1% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for ZEPP.
Why does ZEPP's quarterly revenue fluctuate?
ZEPP quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Zepp Health Corporation's revenue data from 2015 to 2026 shows full historical quarterly detail on this page.
How is ZEPP's revenue distributed by segment?
ZEPP reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does ZEPP's revenue compare to industry peers?
Zepp Health Corporation (ZEPP) with TTM revenue of $1.8B and +38.1% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.